Skip to main content

. 1964 Feb;39(203):1–13. doi: 10.1136/adc.39.203.1

Lead Poisoning in Children

A A Moncrieff, O P Koumides, Barbara E Clayton, A D Patrick, A G C Renwick, G E Roberts

PMCID: PMC2019168 PMID: 14160083

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BESSMAN S. P., LAYNE E. C., Jr Distribution of lead in blood as affected by edathamil calcium-disodium. AMA Am J Dis Child. 1955 Mar;89(3):292–294. doi: 10.1001/archpedi.1955.02050110358005. [DOI] [PubMed] [Google Scholar]
BRADLEY J. E., POWELL A. E., NIERMANN W., MCGRADY K. R., KAPLAN E. The incidence of abnormal blood levels of lead in a metropolitan pediatric clinic; with observation on the value of coproporphyrinuria as a screening test. J Pediatr. 1956 Jul;49(1):1–6. doi: 10.1016/s0022-3476(56)80049-8. [DOI] [PubMed] [Google Scholar]
BYERS R. K. Lead poisoning; review of the literature and report on 45 cases. Pediatrics. 1959 Mar;23(3):585–603. [PubMed] [Google Scholar]
BYERS R. K., MALOOF C. Edathamil calcium-disodium (versenate) in treatment of lead poisoning in children. AMA Am J Dis Child. 1954 May;87(5):559–569. doi: 10.1001/archpedi.1954.02050090547004. [DOI] [PubMed] [Google Scholar]
CHISOLM J. J., Jr, HARRISON H. E. The treatment of acute lead encephalopathy in children. Pediatrics. 1957 Jan;19(1):2–20. [PubMed] [Google Scholar]
CLARK N. S. Lead poisoning in infancy. Arch Dis Child. 1950 Sep;25(123):297–301. doi: 10.1136/adc.25.123.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
CLAYTON B. E., PATRICK A. D. Use of dimercaprol or pencillamine in the treatment of cystinosis. Lancet. 1961 Oct 21;2(7208):909–910. [PubMed] [Google Scholar]
FOREMAN H., FINNEGAN C., LUSHBAUGH C. C. Nephrotoxic hazard from uncontrolled edathamil calcium-disodium therapy. J Am Med Assoc. 1956 Mar 24;160(12):1042–1046. doi: 10.1001/jama.1956.02960470038010. [DOI] [PubMed] [Google Scholar]
GOLDBERG A., SMITH J. A., LOCHHEAD A. C. Treatment of lead-poisoning with oral penicillamine. Br Med J. 1963 May 11;1(5340):1270–1275. doi: 10.1136/bmj.1.5340.1270. [DOI] [PMC free article] [PubMed] [Google Scholar]
KEHOE R. A. The metabolism of lead in man in health and disease. I. The normal metabolism of lead. J R Inst Public Health. 1961 Apr;24:81–97. [PubMed] [Google Scholar]
KENNEDY C. The cerebral metabolic rate in children. Prog Neurobiol. 1956;1:230–238. [PubMed] [Google Scholar]
MCLAUGHLIN M. C. Lead poisoning in children in New York City, 1950-1954; an epidemiologic study. N Y State J Med. 1956 Dec 1;56(23):3711–3714. [PubMed] [Google Scholar]
MELLINS R. B., JENKINS C. D. Epidemiological and psychological study of lead poisoning in children. J Am Med Assoc. 1955 May 7;158(1):15–20. doi: 10.1001/jama.1955.02960010017004. [DOI] [PubMed] [Google Scholar]
MILLICAN F. K., LOURIE R. S., LAYMAN E. M. Emotional factors in the etiology and treatment of lead poisoning; a study of pica in children. AMA J Dis Child. 1956 Feb;91(2):144–149. doi: 10.1001/archpedi.1956.02060020146007. [DOI] [PubMed] [Google Scholar]
OHLSSON W. T. Penicillamine as lead-chelating substance in man. Br Med J. 1962 May 26;1(5290):1454–1456. doi: 10.1136/bmj.1.5290.1454. [DOI] [PMC free article] [PubMed] [Google Scholar]
PETERS R. Significance of biochemical lesions in the pyruvate oxidase system. Br Med Bull. 1953;9(2):116–122. doi: 10.1093/oxfordjournals.bmb.a074325. [DOI] [PubMed] [Google Scholar]
REDDI K. K. Isolation of thorium B (lead)-binding substance from the erythrocytes of rabbit blood. Nature. 1953 Aug 1;172(4370):202–202. doi: 10.1038/172202a0. [DOI] [PubMed] [Google Scholar]
WALSHE J. M. Penicillamine, a new oral therapy for Wilson's disease. Am J Med. 1956 Oct;21(4):487–495. doi: 10.1016/0002-9343(56)90066-3. [DOI] [PubMed] [Google Scholar]
WHITE H. H., FOWLER F. D. Chronic lead encephalopathy. A diagnostic consideration in mental retardation. Pediatrics. 1960 Feb;25:309–315. [PubMed] [Google Scholar]

ACTIONS

RESOURCES